OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.

Antibodies are an important class of proteins with many biomedical and biotechnical applications. Although there are a plethora of experimental techniques geared toward their efficient production, there is a paucity of computational methods for their de novo design. OptCDR is a general computational method to design the binding portions of antibodies to have high specificity and affinity against any targeted epitope of an antigen. First, combinations of canonical structures for the antibody complementarity determining regions (CDRs) that are most likely to be able to favorably bind the antigen are selected. This is followed by the simultaneous refinement of the CDR structures' backbones and optimal amino acid selection for each position. OptCDR is applied to three computational test cases: a peptide from the capsid of hepatitis C, the hapten fluorescein and the protein vascular endothelial growth factor. The results demonstrate that OptCDR can efficiently generate diverse antibody libraries of a pre-specified size with promising antigen affinity potential as exemplified by computationally derived binding metrics.

[1]  L. Harris,et al.  First-Line Herceptin® Monotherapy in Metastatic Breast Cancer , 2001, Oncology.

[2]  Bruce Tidor,et al.  Computational design of antibody-affinity improvement beyond in vivo maturation , 2007, Nature Biotechnology.

[3]  M. Karplus,et al.  Effective energy function for proteins in solution , 1999, Proteins.

[4]  Andrew J. Martin,et al.  Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. , 1996, Journal of molecular biology.

[5]  A. D. de Vos,et al.  Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. , 1999, Journal of molecular biology.

[6]  Peter Timmerman,et al.  Affinity maturation of antibodies assisted by in silico modeling , 2008, Proceedings of the National Academy of Sciences.

[7]  Andrew C. R. Martin,et al.  Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. , 2003, Journal of molecular biology.

[8]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[9]  Hossein Fazelinia,et al.  Extending Iterative Protein Redesign and Optimization (IPRO) in protein library design for ligand specificity. , 2007, Biophysical journal.

[10]  S. L. Mayo,et al.  De novo backbone and sequence design of an idealized α/β-barrel protein: evidence of stable tertiary structure , 2003 .

[11]  S. Muyldermans,et al.  Naturally occurring antibodies devoid of light chains , 1993, Nature.

[12]  J. Kempeni.  Preliminary results of early clinical trials with the fully human anti-TNFα monoclonal antibody D2E7 , 1999, Annals of the rheumatic diseases.

[13]  E. Stura,et al.  Crystal Structure of a Hydrophobic Immunodominant Antigenic Site on Hepatitis C Virus Core Protein Complexed to Monoclonal Antibody 19D9D6 1 , 2003, The Journal of Immunology.

[14]  Jeffrey J. Gray,et al.  Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen docking , 2009, Proteins.

[15]  Frances H Arnold,et al.  Library analysis of SCHEMA‐guided protein recombination , 2003, Protein science : a publication of the Protein Society.

[16]  John R Desjarlais,et al.  A de novo redesign of the WW domain , 2003, Protein science : a publication of the Protein Society.

[17]  K D Wittrup,et al.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Baker,et al.  Design of a Novel Globular Protein Fold with Atomic-Level Accuracy , 2003, Science.

[19]  A. Plückthun,et al.  Tailoring in vitro evolution for protein affinity or stability. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. A. Clark,et al.  An antibody loop replacement design feasibility study and a loop-swapped dimer structure. , 2008, Protein engineering, design & selection : PEDS.

[21]  Andrew J. Martin,et al.  Antibody-antigen interactions: contact analysis and binding site topography. , 1996, Journal of molecular biology.

[22]  K. D. Hardman,et al.  1.85 A structure of anti-fluorescein 4-4-20 Fab. , 1995, Protein engineering.

[23]  Chris Williams.  Oncology , 1990, The Lancet.

[24]  Stephen J Benkovic,et al.  FamClash: A method for ranking the activity of engineered enzymes , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[26]  George A. Khoury,et al.  Computational design of Candida boidinii xylose reductase for altered cofactor specificity , 2009, Protein science : a publication of the Protein Society.

[27]  Hossein Fazelinia,et al.  OptGraft: A computational procedure for transferring a binding site onto an existing protein scaffold , 2008, Protein science : a publication of the Protein Society.

[28]  Woody Sherman,et al.  Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational design , 2006, Protein science : a publication of the Protein Society.

[29]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[30]  P. Kollman,et al.  Encyclopedia of computational chemistry , 1998 .

[31]  Guido Cappuccilli,et al.  A general method for greatly improving the affinity of antibodies by using combinatorial libraries. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Persson,et al.  A focused antibody library for improved hapten recognition. , 2006, Journal of molecular biology.

[33]  A Tramontano,et al.  Antibody modeling: implications for engineering and design. , 2000, Methods.

[34]  A. Plückthun,et al.  In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A R Rees,et al.  WAM: an improved algorithm for modelling antibodies on the WEB. , 2000, Protein engineering.

[36]  D. Figgitt,et al.  Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. , 2003, Drugs.

[37]  O Ouchterlony,et al.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[38]  P. Schleyer.  Encyclopedia of computational chemistry , 1998 .

[39]  Noreen R. Gonzales,et al.  In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  C. Maranas,et al.  IPRO: an iterative computational protein library redesign and optimization procedure. , 2006, Biophysical journal.

[41]  D. Burton,et al.  Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library. , 2009, Journal of molecular biology.

[42]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[43]  Hong Cheng,et al.  De novo design of a single-chain diphenylporphyrin metalloprotein. , 2007, Journal of the American Chemical Society.

[44]  Hiroshi Yanagawa,et al.  In vitro evolution of single-chain antibodies using mRNA display , 2006, Nucleic acids research.

[45]  W. Bretz,et al.  Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.

[46]  A. Lesk,et al.  Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.

[47]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[48]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[49]  J. E. Stacy,et al.  Covalent antibody display—an in vitro antibody-DNA library selection system , 2005, Nucleic acids research.

[50]  Costas D Maranas,et al.  Optimal protein library design using recombination or point mutations based on sequence-based scoring functions. , 2007, Protein engineering, design & selection : PEDS.